X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (216) 216
humans (207) 207
oncology (182) 182
female (140) 140
male (127) 127
middle aged (110) 110
aged (108) 108
lung neoplasms - drug therapy (106) 106
chemotherapy (83) 83
lung neoplasms - pathology (80) 80
lung cancer (79) 79
adult (67) 67
respiratory system (67) 67
carcinoma, non-small-cell lung - drug therapy (65) 65
cancer (58) 58
aged, 80 and over (47) 47
gefitinib (46) 46
lung neoplasms - genetics (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (38) 38
lung cancer, non-small cell (38) 38
non-small cell lung cancer (38) 38
treatment outcome (37) 37
carcinoma, non-small-cell lung - pathology (35) 35
cisplatin (34) 34
mutation (33) 33
cell line, tumor (32) 32
antineoplastic agents - therapeutic use (31) 31
lung neoplasms - mortality (31) 31
pulmonary/respiratory (31) 31
receptor, epidermal growth factor - genetics (31) 31
cisplatin - administration & dosage (29) 29
hematology, oncology and palliative medicine (28) 28
retrospective studies (28) 28
survival (28) 28
antineoplastic agents - pharmacology (27) 27
carcinoma, non-small-cell lung - genetics (27) 27
neoplasm staging (27) 27
prognosis (27) 27
animals (26) 26
carcinoma, non-small-cell lung - mortality (26) 26
docetaxel (24) 24
research (23) 23
respiratory agents (23) 23
tumors (23) 23
adenocarcinoma (22) 22
carboplatin (22) 22
care and treatment (21) 21
mutations (21) 21
quinazolines - therapeutic use (21) 21
survival analysis (21) 21
adenocarcinoma - drug therapy (20) 20
analysis (20) 20
epidermal growth factor (20) 20
erlotinib (20) 20
mice (20) 20
survival rate (20) 20
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
carcinoma (19) 19
expression (19) 19
resistance (19) 19
non-small-cell lung cancer (18) 18
oncology, experimental (18) 18
radiotherapy (18) 18
therapy (18) 18
trial (18) 18
adenocarcinoma - pathology (17) 17
camptothecin - analogs & derivatives (17) 17
drug resistance, neoplasm (17) 17
japan (17) 17
receptor, epidermal growth factor - antagonists & inhibitors (17) 17
tomography, x-ray computed (17) 17
adenocarcinoma - genetics (16) 16
antineoplastic agents - adverse effects (16) 16
combined modality therapy (16) 16
etoposide (16) 16
lung neoplasms - metabolism (16) 16
lung neoplasms - radiotherapy (16) 16
lung neoplasms - therapy (16) 16
medicine & public health (16) 16
egfr (15) 15
genetic aspects (15) 15
medical colleges (15) 15
medicine, general & internal (15) 15
metaanalysis (15) 15
acquired-resistance (14) 14
clinical trials (14) 14
follow-up studies (14) 14
lung neoplasms - diagnosis (14) 14
pharmacology & pharmacy (14) 14
cisplatin - adverse effects (13) 13
egfr mutation (13) 13
gene (13) 13
medicine (13) 13
medicine, research & experimental (13) 13
metastasis (13) 13
quinazolines - pharmacology (13) 13
respiratory tract diseases (13) 13
taxoids - administration & dosage (13) 13
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
carcinoma, small cell - pathology (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. 1438 - 1440
Journal Article
Translational Cancer Research, ISSN 2218-676X, 2016, Volume 5, Issue S6, pp. S1248 - S1254
Mesenchymal-to-epithelial transition (MET) exon 14 mutation in non-small cell lung cancer (NSCLC) has been recognized. However, clinical, molecular, and... 
Mesenchymal-to-epithelial transition (MET) | Tyrosine kinase inhibitor (TKI) | Non-small cell lung cancer (NSCLC) | mesenchymal-to-epithelial transition (MET) | NSCLC | ADENOCARCINOMAS | ACQUIRED-RESISTANCE | AMPLIFICATION | ONCOLOGY | C-MET | CRIZOTINIB | tyrosine kinase inhibitor (TKI) | EXPRESSION | ERLOTINIB | REVEALS
Journal Article
Thorax, ISSN 0040-6376, 08/2019, Volume 74, Issue 8, pp. 821 - 822
Physical examination revealed normal percussion and auscultation findings for both lungs, a blood pressure of 110/60 mm Hg, peripheral oxygen saturation of 97%... 
imaging/ct mri etc | bronchoscopy | Cardiac arrhythmia | Pneumonia | Medical imaging | Biopsy | Catheters | Veins & arteries | Index Medicus | Chest Clinic | 2313 | 1506 | imaging | ct mri etc
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3299 - 3306
Journal Article
Experimental Cell Research, ISSN 0014-4827, 03/2014, Volume 322, Issue 1, pp. 168 - 177
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 01/2013, Volume 104, Issue 1, pp. 78 - 84
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 04/2018, Volume 14, pp. 753 - 756
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, pp. 20113 - 20113
Journal Article